Eledon Pharmaceuticals ELDN
NASDAQ ELDN
$3.02 +0.09 (+3.07%)
As of: Sep 4, 2026 · 3:59 PM EDT

Eledon Pharmaceuticals (ELDN) Treasury Shares (2013 - 2026)

Eledon Pharmaceuticals' (ELDN) quarterly Treasury Shares came in at $110086.0 in Q1 2026, little changed YoY from $110086.0 in Q1 2025, and little changed on a QoQ basis from $110086.0 in Q4 2025.

Analysis

Eledon Pharmaceuticals (ELDN) Treasury Shares (2013 - 2026) Analysis & Trends

Eledon Pharmaceuticals (ELDN) has 12 years of Treasury Shares data on file, last reported at $110086.0 in Q1 2026.

  • Quarterly Treasury Shares changed 0.0% year-over-year to $110086.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $110086.0 (changed 0.0% YoY) and the FY2025 annual result came in at $110086.0, changed 0.0% from the prior year.
  • Treasury Shares was little changed at $110086.0 in Q1 2026, from $110086.0 in the prior quarter.
  • In the past five years, Treasury Shares ranged from a high of $110086.0 in Q1 2024 to a low of $4422.0 in Q4 2023.
  • A 5-year average of $82230.2 and a median of $110086.0 in 2024 frame the typical range for Treasury Shares.
  • Annual changes were most pronounced in 2024 — Treasury Shares soared 2389.51% — and 2025, when it tumbled 95.98%.
  • Tracing ELDN's Treasury Shares over 5 years: stood at $15000.0 in 2022, then tumbled by 70.52% to $4422.0 in 2023, then soared by 2389.51% to $110086.0 in 2024, then changed by 0.0% to $110086.0 in 2025, then changed by 0.0% to $110086.0 in 2026.
  • The last three Treasury Shares figures came in at $110086.0 (Q1 2026), $110086.0 (Q4 2025), and $4422.0 (Q3 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Treasury Shares (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 36.40 Mn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn -
5 Revolution Medicines 44.33 Bn 44.33 Bn - -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn -
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn -
8 Royalty Pharma 28.45 Bn 27.61 Bn - 2.72 Mn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn -
10 Eledon Pharmaceuticals 344.87 Mn 344.87 Mn - 75,800.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 75,800.00
Jun 30, 2026 75,800.00
Mar 31, 2026 110,086.00
Mar 31, 2026 110,086.00
Dec 31, 2025 110,086.00
Dec 31, 2025 110,086.00
Sep 30, 2025 110,086.00
Sep 30, 2025 110,086.00
Jun 30, 2025 110,086.00
Jun 30, 2025 110,086.00
Mar 31, 2025 110,086.00
Mar 31, 2025 110,086.00
Dec 31, 2024 110,086.00
Dec 31, 2024 110,086.00
Sep 30, 2024 110,086.00
Sep 30, 2024 110,086.00
Jun 30, 2024 110,086.00
Jun 30, 2024 110,086.00
Mar 31, 2024 110,086.00
Mar 31, 2024 110,086.00